The new laboratory space will increase the company’s pace of discovery for potential therapeutics including multiple chronic disease indications and will enhance the development of treatment ...

Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...

Rein Therapeutics, Inc. (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to ...

Researchers discuss how organoids and organ-on-a-chip technologies are transforming women’s health research. By mimicking ...

Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary fibrosis (IPF) in the ...

When combined with clinically validated growth factor serums, microchanneling can enhance skin rejuvenation, effectively ...